Publicaciones en colaboración con investigadores/as de French Institute of Health and Medical Research (19)

2024

  1. Extending the phenotypic spectrum assessed by the CDR plus NACC FTLD in genetic frontotemporal dementia

    Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, Vol. 16, Núm. 2

  2. Impaired glymphatic system in genetic frontotemporal dementia: a GENFI study

    Brain Communications, Vol. 6, Núm. 4

  3. Longitudinal cerebral perfusion in presymptomatic genetic frontotemporal dementia: GENFI results

    Alzheimer's and Dementia, Vol. 20, Núm. 5, pp. 3525-3542

2023

  1. Cerebellar and subcortical atrophy contribute to psychiatric symptoms in frontotemporal dementia

    Human Brain Mapping, Vol. 44, Núm. 7, pp. 2684-2700

  2. Language impairment in the genetic forms of behavioural variant frontotemporal dementia

    Journal of Neurology, Vol. 270, Núm. 4, pp. 1976-1988

  3. Motor symptoms in genetic frontotemporal dementia: developing a new module for clinical rating scales

    Journal of Neurology, Vol. 270, Núm. 3, pp. 1466-1477

  4. Temporal dynamics predict symptom onset and cognitive decline in familial frontotemporal dementia

    Alzheimer's and Dementia, Vol. 19, Núm. 5, pp. 1947-1962

2022

  1. CSF glial markers are elevated in a subset of patients with genetic frontotemporal dementia

    Annals of Clinical and Translational Neurology, Vol. 9, Núm. 11, pp. 1764-1777

  2. Cognitive composites for genetic frontotemporal dementia: GENFI-Cog

    Alzheimer's Research and Therapy, Vol. 14, Núm. 1

  3. Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementia

    Alzheimer's Research and Therapy, Vol. 14, Núm. 1

  4. Examining empathy deficits across familial forms of frontotemporal dementia within the GENFI cohort

    Cortex, Vol. 150, pp. 12-28

  5. Structural brain splitting is a hallmark of Granulin-related frontotemporal dementia

    Neurobiology of Aging, Vol. 114, pp. 94-104

  6. The CBI-R detects early behavioural impairment in genetic frontotemporal dementia

    Annals of Clinical and Translational Neurology, Vol. 9, Núm. 5, pp. 644-658

2021

  1. Differential early subcortical involvement in genetic FTD within the GENFI cohort

    NeuroImage: Clinical, Vol. 30

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  3. Progression of Behavioral Disturbances and Neuropsychiatric Symptoms in Patients with Genetic Frontotemporal Dementia

    JAMA Network Open, Vol. 4, Núm. 1

  4. The Revised Self-Monitoring Scale detects early impairment of social cognition in genetic frontotemporal dementia within the GENFI cohort

    Alzheimer's Research and Therapy, Vol. 13, Núm. 1

2013

  1. Anti-tumour immunotherapy with Vγ9Vδ2 T lymphocytes: From the bench to the bedside

    British Journal of Haematology, Vol. 160, Núm. 2, pp. 123-132

2011

  1. γδT-cell killing of primary follicular lymphoma cells is dramatically potentiated by GA101, a type II glycoengineered anti-CD20 monoclonal antibody

    Haematologica, Vol. 96, Núm. 3, pp. 400-407